Do new cancer drugs offer good value for money? The perspectives of oncologists, health care policy makers, patients, and the general population

Do new cancer drugs offer good value for money? The perspectives of oncologists, health care policy makers, patients, and the general population

Tatiana Dilla,1 Luís Lizan,2 Silvia Paz,2 Pilar Garrido,3 Cristina Avendaño,4 Juan J Cruz-Hernández,5 Javier Espinosa,6 José A Sacristán1 1Medical Department, Lilly, Madrid, 2Outcomes’10, Jaime I University, Castellón, 3Med...

Full description

Bibliographic Details
Main Authors: Dilla T, Lizan L, Paz S, Garrido P, Avendaño C, Cruz-Hernández JJ, Espinosa J, Sacristán JA
Format: Article
Language:English
Published: Dove Medical Press 2015-12-01
Series:Patient Preference and Adherence
Subjects:
Oncology
value
cost
cost-effectiveness
healthcare policy makers
patients
general population.
Online Access:https://www.dovepress.com/do-new-cancer-drugs-offer-good-value-for-money-the-perspectives-of-onc-peer-reviewed-article-PPA

Internet

https://www.dovepress.com/do-new-cancer-drugs-offer-good-value-for-money-the-perspectives-of-onc-peer-reviewed-article-PPA

Similar Items